For more VICC news, visit their website »
Heather Jackson, PhD, APRN, administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center, has been elected a fellow of the American Association of Nurse Practitioners.
Sonya Reid, MD, MPH, assistant professor of Medicine in the Division of Hematology Oncology, is a member of the Vanderbilt-Ingram Cancer Center Breast Cancer Research Program and sees patients at Vanderbilt Health One Hundred Oaks.
A new clinical trial seeks to determine whether immunotherapy in combination with short-course radiation followed by surgical resection could be a curative treatment for locally advanced rectal cancer.
Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.
Nancy Davis, MD, has been promoted to Vice President for Cancer Care Network and Strategy at Vanderbilt University Medical Center, a new position responsible for developing provider relationships with other health care systems and expanding access to oncology care throughout Tennessee and other states.
A team of Vanderbilt researchers have shown in a preclinical study that the investigational drug rigosertib could be a potential booster treatment to elicit response to immunotherapies among melanoma patients.
Accessibility Tools